Sodium iodide (I-131) capsule T Curium

Sodium iodide (I-131) capsule T Curium is a medicine authorised by Swissmedic under authorisation number 52728. The authorisation holder is b.e.imaging.ag. The medicinal product code is Radiopharmaceuticals and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 August 1994 and the authorisation is valid without a time limit. ATC code V10XA01 places the medicine in the group Therapeutic radiopharmaceuticals.

  • Dispensing category A
  • Authorisation number 52728
  • ATC V10XA01
  • Radiopharmaceuticals
Authorisation data
Authorisation number52728
NameSodium iodide (I-131) capsule T Curium
Full nameSodium iodide (I-131) capsule T Curium, Therapiekapseln
Authorisation holderb.e.imaging.ag
Medicinal product codeRadiopharmaceuticals
Dispensing categoryA · Prescription, not repeatable
ATC codeV10XA01
First authorisation09 August 1994
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Sodium iodide (I-131) capsule T Curium, TherapiekapselnA09 August 1994

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Kapsel(n)V10XA0117.02.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Sodium iodide (I-131) capsule T Curium authorised in Switzerland?

Yes. Sodium iodide (I-131) capsule T Curium is authorised by Swissmedic under authorisation number 52728, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Sodium iodide (I-131) capsule T Curium have?

Sodium iodide (I-131) capsule T Curium is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Sodium iodide (I-131) capsule T Curium?

The authorisation holder is b.e.imaging.ag. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com